UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000042437
Receipt No. R000048446
Scientific Title Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021
Date of disclosure of the study information 2020/11/13
Last modified on 2020/11/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021
Acronym Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021
Scientific Title Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021
Scientific Title:Acronym Japanese lung cancer registry study: Japanese joint committee of lung cancer registry database of patients who underwent resections in 2021
Region
Japan

Condition
Condition Primary lung cancer
Classification by specialty
Chest surgery
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 The purpose of this study is to assess the clinicopathological features of resected primary lung cancer in 2021in a large registry population in Japan.
Basic objectives2 Others
Basic objectives -Others These registration data will contribute to improving the UICC TNM classification.
Trial characteristics_1 Others
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes A nationwide prospective registry study utilizing NCD data on the prognosis and clinicopathological profiles of resected lung cancer in 2021
Key secondary outcomes To identify predictive factors of surgical outcome for lung cancer treated in 2021

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1 Patient enrolled from institutions participating in this study that wish to participate in university hospitals and regional core facilities nationwide
2 Patients aged 20 years or older
3 Patients undergoing surgical treatment from January 1, 2021, to December 31, 2021
4 Except for diagnostic procedures
5 Include patients who have resulted in exploratory thoracotomy
Key exclusion criteria 1 Patient who declined to participate in the study
2 patient undergoing diagnostic surgery
Target sample size 15000

Research contact person
Name of lead principal investigator
1st name Ichiro
Middle name
Last name Yoshino
Organization Chiba University Graduate School of Medicine
Division name General Thoracic Surgery
Zip code 260-8670
Address 1-8-1, Inohana, Chuo-ku, Chiba-city, Chiba
TEL 043-222-7171
Email 1royoshino@gmail.com

Public contact
Name of contact person
1st name Hidemi
Middle name
Last name Suzuki
Organization Chiba University Graduate School of Medicine
Division name General Thoracic Surgery
Zip code 260-8670
Address 1-8-1, Inohana, Chuo-ku, Chiba-city, Chiba
TEL 0432227171
Homepage URL https://haigan-touroku.jp/11ji/index.html
Email src-jjclcr@haigan-touroku.org

Sponsor
Institute Japanese Joint Committee of Lung Cancer Registry
Institute
Department

Funding Source
Organization Japanese Joint Committee of Lung Cancer Registry
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Japanese Joint Committee of Lung Cancer Registry
Address 1-8-1, Inohana, Chuo-ku, Chiba-city, Chiba
Tel 0432227171
Email src-jjclcr@haigan-touroku.org

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 11 Month 13 Day

Related information
URL releasing protocol https://haigan-touroku.jp/11ji/index.html
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 11 Month 02 Day
Date of IRB
2020 Year 11 Month 02 Day
Anticipated trial start date
2021 Year 01 Month 01 Day
Last follow-up date
2029 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The Japanese Joint Committee of Lung Cancer Registry (JJCLCR) conducts nationwide
registry studies of lung cancer patients utilizing NCD data. This is the 11th JJCLCR registry study for lung cancer
patients surgically treated in 2021.

Management information
Registered date
2020 Year 11 Month 13 Day
Last modified on
2020 Year 11 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048446

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.